Veracyte (VCYT) EBITDA Margin Growth (5y) (2017 - 2026)
Veracyte (VCYT) EBITDA Margin Growth (5y) (2017 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.44 Bn | 209.37 Bn | 8.34 Bn |
| 2 | Danaher | 139.95 Bn | 135.60 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.16 Bn | 45.96 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.67 Bn | 37.87 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.29 Bn | 37.21 Bn | 1.44 Bn |
| 6 | Natera | 38.61 Bn | 37.51 Bn | 696.04 Mn |
| 7 | Illumina | 29.99 Bn | 28.82 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.51 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.17 Bn | 25.55 Bn | 1.03 Bn |
| 10 | Veracyte | 3.68 Bn | 3.38 Bn | 108.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2,885.00 |
| Mar 31, 2026 | 14,002.00 |
| Dec 31, 2025 | 4,982.00 |
| Sep 30, 2025 | 3,047.00 |
| Jun 30, 2025 | 4,933.00 |
| Mar 31, 2025 | 4,174.00 |
| Dec 31, 2024 | 3,109.00 |
| Sep 30, 2024 | 1,606.00 |
| Jun 30, 2024 | 1,431.00 |
| Mar 31, 2024 | 219.00 |
| Dec 31, 2023 | -2,429.00 |
| Sep 30, 2023 | -1,688.00 |
| Jun 30, 2023 | 1,709.00 |
| Mar 31, 2023 | 3,195.00 |
| Dec 31, 2022 | 2,409.00 |
| Sep 30, 2022 | 2,354.00 |
| Jun 30, 2022 | 2,118.00 |
| Mar 31, 2022 | 2,325.00 |
| Dec 31, 2021 | 180.00 |
| Sep 30, 2021 | -137.00 |